Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Aug 24, 2012

30071_dirs_2012-08-24_6195b1c8-4e6f-4e04-8b25-a11a6aca231c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-22

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-22 ResMed Common Stock M 25000 $23.095 Acquired 77968.86 Direct
2012-08-22 ResMed Common Stock S 25000 $37.00 Disposed 52968.86 Direct
2012-08-24 ResMed Common Stock A 45715 Acquired 98683.86 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-22 ResMed Common Stock Options $23.095 M 25000 Disposed 2013-11-10 ResMed Common Stock (25000) Direct

Footnotes

F1: Represents date grant first became exercisable. Options vest 1/4 annually.

F2: Represents performance-based restricted stock units initially granted on November 16, 2011, but earned as of August 24, 2012, based on company performance.